Search

everythinglearnresearchcommunity

for

Search:↓

PCOS patients have more central body fat, which can be effectively measured using DEXA.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

The Rotterdam Study aims to understand various diseases in older adults.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Obesity greatly affects polycystic ovarian syndrome, and losing weight should be the first treatment for obese patients to improve their chances of ovulation and pregnancy.

PCOS has no cure, but treatments can manage symptoms and improve health.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Sex hormones affect liver fat and metabolic health differently in men and women.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Functional nutrition evaluations can improve personalized wellness programs and help prevent chronic diseases.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Obesity and BMI don't differ among PCOS types, but teens should learn about long-term health risks.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.